Efficacy and Safety of Metreleptin Therapy in Patients With Type 1 Diabetes: A Pilot Study.

Chandna VasandaniGregory O ClarkBeverley Adams-HuetClaudia QuittnerAbhimanyu Garg

Published in: Diabetes care (2017)

Metreleptin is safe but may not be efficacious in improving glycemic control in patients with T1DM, although it reduces body weight and daily insulin dose modestly.

Keyphrases

glycemic control
body weight
type diabetes
blood glucose
weight loss
insulin resistance
physical activity
stem cells
skeletal muscle